Cefazolin prophylaxis in obese women undergoing cesarean delivery

Obstetrics and Gynecology

Volumn 125, Issue 5, 2015, Pages 1205-1210

  Maggio, Lindsay ^a,b   Nicolau, David P ^a,b   Dacosta, Melissa ^a,b   Rouse, Dwight J ^a,b   Hughes, Brenna L ^a,b  

^a BROWN UNIVERSITY   (United States)

^b HARTFORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFAZOLIN; ANTIINFECTIVE AGENT;

ADULT; BODY MASS; CESAREAN SECTION; CONFERENCE PAPER; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; FEMALE; GESTATIONAL AGE; HEMATOMA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INCISION; MAJOR CLINICAL STUDY; OBESITY; POSTOPERATIVE COMPLICATION; PRENATAL PERIOD; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; STAPHYLOCOCCUS; STAPHYLOCOCCUS INFECTION; SUBCUTANEOUS FAT; WOUND COMPLICATION; WOUND DEHISCENCE; WOUND INFECTION; ANTIBIOTIC PROPHYLAXIS; DOSE RESPONSE; METABOLISM; SURGICAL WOUND INFECTION; YOUNG ADULT;

ADULT; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BODY MASS INDEX; CEFAZOLIN; CESAREAN SECTION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; SUBCUTANEOUS FAT; SURGICAL WOUND INFECTION; YOUNG ADULT;

EID: 84928128162     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000000789     Document Type: Conference Paper

References (12)

1. Toma O, Suntrup P, Stefanescu A, London A, Mutch M, Kharasch E. Pharmacokinetics and tissue penetration of cefoxitin in obesity: implications for risk of surgical site infection. Anesth Analg 2011;113:730-7.
2. Anderson DJ, Kaye KS, Classen D, Arias KM, Podgorny K, Burstin H, et al. Strategies to prevent surgical site infections in acute care hospitals. Infect Control Hosp Epidemiol 2008;29 (suppl 1):S51-61.
3. DeFrances CJ, Cullen KA, Kozak LJ. National Hospital Discharge Survey: 2005 annual summary with detailed diagnosis and procedure data. Vital Health Stat 13 2007;1-209.
4. Tita AT, Rouse DJ, Blackwell S, Saade GR, Spong CY, Andrews WW. Emerging concepts in antibiotic prophylaxis for cesarean delivery: a systematic review. Obstet Gynecol 2009;113:675-82.
5. Martin JA, Hamilton BE, Ventura SJ, Osterman MJ, Mathews TJ. Births: final data for 2011. Natl Vital Stat Rep 2013;62:1-69, 72.
6. Dinsmoor MJ, Gilbert S, Landon MB, Rouse DJ, Spong CY, Varner MW, et al. Perioperative antibiotic prophylaxis for nonlaboring cesarean delivery. Obstet Gynecol 2009;114: 752-6.
7. Bratzler DW, Dellinger EP, Olsen KM, Perl TM, Auwaerter PG, Bolon MK, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Surg Infect (Larchmt) 2013;14:73-156.
8. Use of prophylactic antibiotics in labor and delivery. Practice Bulletin No. 120. American College of Obstetricians and Gynecologists. Obstet Gynecol 2011;117: 1472-83.
9. Dudley MN, Nightingale CH, Drezner AD, Low HB, Quintiliani R. Comparative penetration of cefonicid and cefazolin into the atrial appendage and pericardial fluid of patients undergoing open-heart surgery. Antimicrob Agents Chemother 1984;26:347-50.
10. Pevzner L, Swank M, Krepel C, Wing DA, Chan K, Edmiston CE Jr. Effects of maternal obesity on tissue concentrations of prophylactic cefazolin during cesarean delivery. Obstet Gynecol 2011;117:877-82.
11. CLSI. Performance standards for antimicrobial susceptibility testing; twenty-second informational supplement. CLSI document M100-S22. Wayne (PA): Clinical and Laboratory Standards Institute; 2012.
12. Stitely M, Sweet M, Slain D, Alons L, Holls W, Hochberg C, et al. Plasma and tissue cefazolin concentrations in obese patients undergoing cesarean delivery and receiving differing pre-operative doses of drug. Surg Infect (Larchmt) 2013;14: 455-9.